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ApoptosisTrans fats are not a homogeneous group of molecules and less is known about the cellular effects of individual
members of the group. Vaccenic acid (VA) and elaidic acid (EA) are the predominant trans monoenes in ru-
minant fats and vegetable oil, respectively. Here, we investigated the mechanism of cell death induced by VA
and EA on primary rat ventricular myoﬁbroblasts (rVF). The MTT assay demonstrated that both VA and EA
(200 μM, 0–72 h) reduced cell viability in rVF (Pb0.001). The FACS assay conﬁrmed that both VA and EA
induced apoptosis in rVF, and this was concomitant with elevation in cleaved caspase-9, -3 and -7, but not
caspase-8. VA and EA decreased the expression ratio of Bcl2:Bax, induced Bax translocation to mitochondria
and decrease in mitochondrial membrane potential (Δψ). BAX and BAX/BAK silencing in mouse embryonic ﬁ-
broblasts (MEF) inhibited VA and EA-induced cell death compared to the corresponding wild type cells.
Transmission electron microscopy revealed that VA and EA also induced macroautophagosome formation
in rVF, and immunoblot analysis conﬁrmed the induction of several autophagy markers: LC3-β lipidation,
Atg5–12 accumulation, and increased beclin-1. Finally, deletion of autophagy genes, ATG3 and ATG5 signiﬁ-
cantly inhibited VA and EA-induced cell death (Pb0.001). Our ﬁndings show for the ﬁrst time that trans fat
acid (TFA) induces simultaneous apoptosis and autophagy in rVF. Furthermore, TFA-induced autophagy is
required for this pro-apoptotic effect. Further studies to address the effect of TFA on the heart may reveal
signiﬁcant translational value for prevention of TFA-linked heart disease.
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The impact of diet on the incidence of cardiovascular disease is well
established, and nutrition may be responsible for ~40% of all cardiovas-
cular disease (Canadian government report-Health Canada issued in
1995). Recent data indicate that the majority of myocardial infarctions
(MI) are directly linked to modiﬁable environmental factors, including
diet [1], in particular the relative intake of saturated fatty acids (SFA)
and polyunsaturated fats (PUFAs) [2,3]. Trans fatty acids (TFA) are un-
saturated fatty acids with at least one double bond in the trans conﬁgu-
ration that renders them structurally/chemically unstable compared to
saturated SFAs [4]. Elaidic acid (18:1 trans-9) is the main TFA isomer in
hydrogenated vegetable oils and products containing hydrogenated
margarines or vegetable shortening including fried foods, cookies, and
crackers, and accumulates in atherosclerotic lesions and adipose tissue
of obese patient [4–6]. Health professionals support removal or reduc-
tion of dietary TFAs for improved health [7,8]. This notwithstanding,
2275S. Ghavami et al. / Biochimica et Biophysica Acta 1823 (2012) 2274–2286some recent evidence indicates that speciﬁc isomeric conﬁguration in
different TFAs may exhibit different effect(s) on cardiovascular health
[7]. Vaccenic acid (18:1 trans-11) is unique in structure and source, as
it is enriched in dairy products and meats of ruminant species [9].
Several recent in vitro studies indicate that saturated fatty acids
induce apoptosis (programmed cell death I) in somatic and cancer
cells of many different origins, including cardiomyocytes and ﬁbro-
blasts [10–21]. Though a recent report suggests a role for autophagy
in TFA-induced cell death of hepatocytes [22], apoptosis is generally
accepted as the principal mechanism driving cell demise in health
and disease [23–26]. Apoptosis can be initiated via extrinsic and/or
intrinsic pathways [24,27], driven by the activation of caspases.
Macroautophagy is an evolutionarily conserved catabolic, homeostat-
ic process that can support cell survival or, if excessive, can drive cell
death. It consists of membrane isolation, autophagosome and
autolysosome formation [28,29], the later driving breakdown of mac-
romolecules and organelles by lysosomal enzymes [28,30,31]. Apo-
ptosis and autophagy have many common regulators, and cross-talk
regulates cell fate in response to cellular stress. The complex interac-
tion of apoptotic and autophagic pathways necessitates the careful
consideration of their integrated control and impact on cell fate to un-
derstand cell death phenomena [32,33].
Fibroblasts are a heterogeneous group of cells that exhibit distinct
differentiated phenotypes in different organs [34]. In humans cardiac
ﬁbroblasts represent the most numerous non-myocytes in the myo-
cardium, with these cells synthesizing and organizing collagens, ﬁ-
bronectins and other interstitial components to maintain the
integrity of the cardiac extracellular matrix (matrix) [35]. In the cur-
rent paper, we address the cell death effects of elaidic and vaccenic
TFAs on rat ventricular myoﬁbroblasts (rVF), dissecting the roles of
apoptosis and autophagy and cross-talk between these pathways.
2. Materials and methods
2.1. Materials and reagents
Cell culture plasticwarewas obtained from theCorning Costar Compa-
ny (Thermo Fisher Canada). Cell culture media, propidium iodide (PI),
rabbit anti-LC3β, rabbit anti-beta actin, 3-(4,5-dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide (MTT), vaccenic acid, elaidic acid,
and vitamin C were obtained from Sigma (Sigma-Aldrich, Oakville,
Canada). Rabbit anti-cleaved caspase-7, -8, rabbit anti-Bak, Bax,
Bcl2, Atg12, Atg3, Atg5, cleaved caspase-3, and cleaved caspase-9
were purchased from Cell Signaling (MA, USA). 5,5′,6,6′-Tetrachloro-
1,1′,3,3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1),Mitotracker
Red, was obtained from Life Technologies Inc. (Burlington, Canada).
Caspase-Glo®-3/7, Caspase-Glo®-8 and Caspase-Glo®-9 assay were pur-
chased from Promega (WI, USA).
2.2. Primary cardiac ﬁbroblast preparation
Cardiac ﬁbroblasts were isolated as previously described [36,37].
Brieﬂy, hearts from adult male Sprague–Dawley rats (150–200 g) were
subjected to Langendorff perfusion with DMEM-F-12 (GIBCO) followed
by serum-freeMEM (SMEM; Life Technologies, Inc., Burlington, Canada).
Perfused hearts were digested with 0.1% wt/vol collagenase type 2
(Worthington) in SMEM for 20 min. Hearts were minced in dilute
collagenase solution (0.05% wt/vol collagenase type 2 in SMEM)
for a further 15 min before addition of growth media DMEM-F-12
supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin
(GIBCO-BRL), 100 μg/ml streptomycin (GIBCO BRL), and 1 μM ascorbic
acid (Sigma-Aldrich). Upon settling of large tissue pieces to the bottom
of a 50-ml tube, supernatant was centrifuged at 2000 rpm for 5 min.
Cell pellets were re-suspended in growth media and plated on 75-cm2
cultureﬂasks. Cellswere allowed to adhere for 2–3 h in a 5%CO2 37 °C in-
cubator, thenwashed twicewith phospho-buffered saline (PBS) followedby the addition of fresh growthmedia.Mediawere changed the following
day, and cells were allowed to grow for 3–4 days before passaging into
ﬁrst passage (P1) myoﬁbroblasts. P1 myoﬁbroblasts were transferred to
DMEM/F12 media and after 24 h all cultures have been done in DMEM
medium. For all experiments, passages 3–7 of rat cardiac myoﬁbroblast
were used in DMEM/F12 complete media.2.3. Cell viability assay
Wemeasured the viability of cardiac myoﬁbroblasts under various
treatment conditions, as described previously using MTT [38,39].
Brieﬂy, primary cardiac myﬁbroblasts, wild type murine embryonic
ﬁbroblasts (Wt MEF), MEF Bax knock out (MEF Bax−/−), and MEF
Bax/Bak double knock out (MEF Bax/Bak−/−) cells were treated with
vaccenic or elaidic acid (0–400 μM, 0–72 h). Relative cell viability
(percent of control) was calculated using the equation: (mean OD of
treated cells/mean OD of control cells)×100. For each time point,
the treated cells were compared with control cells that had been
treated with vehicle only (DMSO, 0.1% V/V). In experiments investi-
gating if vitamin C can modulate the cytotoxic effects of vaccenic
and elaidic acids, vitamin C (2.5 and 5 mM) was added to culture
media 4 h before the treatment and later the cells were co-treated
with vaccenic and elaidic acids (200 μM, 72 h).2.4. Measurement of apoptosis by ﬂow cytometry
Apoptosis in our cell preparations was measured using the
Nicoletti method [40,41]. Brieﬂy, cells grown in 12-well plates were
treated with 200 and 400 μM vaccenic and elaidic acids for the indicat-
ed time intervals. After scraping, the cells were harvested by centrifuga-
tion at 1500×g for 5 min,washed oncewith phosphate-buffered saline,
and resuspended in hypotonic propidium iodide lysis buffer (1% sodium
citrate, 0.1% Triton X-100, 0.5 mg/ml RNase A, 40 μg/ml propidium io-
dide). Cellular nuclei were incubated for 30 min at 30 °C and subse-
quently analyzed by ﬂow cytometry. Nuclei to the left of the G1 peak
containing hypo-diploid DNA were considered apoptotic.2.5. Luminescence caspase activity assays
Luminometric assays Caspase-Glo® 8, 9 and 3/7 (Promega, Canada,
Nepean, ON) were used to measure the proteolytic activity of
caspases-3/7 (DEVD-ase), 8 (IETD-ase), and 9 (LEHD-ase) as we have
previously done [42].2.6. Measuring mitochondrial membrane potential
Mitochondrial membrane potential was measured employing the
mitochondria-speciﬁc cationic ratiometric dye JC-1 that undergoes
ΔΨm-dependent aggregation in the mitochondria. Normally, JC-1 ex-
ists as a green ﬂuorescent (540 nm, excitation 490 nm) monomer at
ΔΨmb140 mV, but when ΔΨm>140 mV, then JC-1 aggregates and
emits red spectra ﬂuorescence (590 nm, excitation 540 nm). We
measured the ΔΨm of cardiac myoﬁbroblasts under various treatment
conditions, as described previously [43].2.7. Analysis of cellular morphology
To assess cell viability based on gross cellular appearance (chro-
matin condensation and cell shrinkage) rat cardiac myoﬁbroblast
cells were grown on 12-well plates and morphology was assessed
by phase contrast microscopy (Olympus CKX41) using a Olympus In-
ﬁnity 1 CCD digital camera to capture images.
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We used Western blotting to detect cleaved caspase-8, -3, -9,
-Bcl2, Bid, Bax, LC3β, Atg5–12, Atg3, Atg5, and β actin. Brieﬂy, cells
were washed and protein extracts prepared in lysis buffer (20 mM
Tris–HCl (pH 7.5), 0.5% Nonidet P-40, 0.5 mM PMSF, 100 μM
β-glycerol 3-phosphate and 0.5% protease inhibitor cocktail). After aA 24 hrs B
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Fig. 1. Trans fats (vaccenic or elaidic acid) induce apoptosis in primary rat ventricular myo
(200 and 400 μM) and cell viability was assessed 24 and 72 h thereafter by MTT assay. Co
expressed as percentage of corresponding time point control and represent the means±SD
(***Pb0.001). (C) Examples of typical DNA histograms showing propidium iodide staining
tricular myoﬁbroblast. In each panel the region labeled “M2” indicates cells with sub-diploi
(G1) and tetraploid (G2) nuclear staining in non-apoptotic cells are visible in the region labe
dence control for 24 (top row) and 72 (bottom row) hours. (D) Percent sub-G1 rat ventricu
or ethanol solvent control after 72 h. Results represent the means±SD of 4 independent
(statistical signiﬁcance is indicated by ***Pb0.001 vs time-matched controls).high-speed spin (13,000×g for 10 min), the supernatant protein con-
tent was determined by Lowry protein assay and then proteins were
size-fractionated by SDS-PAGE and transferred onto nylon mem-
branes under reducing conditions. After blocking membranes with
non-fat dried milk and Tween 20, blots were incubated overnight
with the primary antibodies at 4 °C. HRP-conjugated secondary anti-
body incubation was carried out for 1 h at room temperature. Blots72 hrs  
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ﬁbroblasts. (A, B) Cardiac myoﬁbroblasts were treated with vaccenic and elaidic acids
ntrol cells for each time point were treated with vehicle control (ethanol). Results are
of 8 independent experiments in three different primary rat ventricular myoﬁbroblast
measured by ﬂow cytometry for control and vaccenic and elaidic acid-treated rat ven-
d DNA and the percentage of cells within those regions are indicated. Peaks for diploid
led as “M1”. The cells were treated with vaccenic and elaidic acids and their correspon-
lar myoﬁbroblast abundance induced by vaccenic and elaidic acids (200 and 400 μM)
experiments in two different primary rat ventricular myoﬁbroblast primary cell lines
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tion (Amersham-Pharmacia Biotech). In experiments detecting Bak
oligomerization, non-reducing immunoblotting was used.
2.9. Immunocytochemistry, confocal imaging and electron microscopy
To carry out immunocytochemistry, MEF Bax-GFP cells were
grown overnight on coverslips and then treated with vaccenic and
elaidic acids (200 μM) for 72 h prior to ﬁxation (4% paraformalde-
hyde/120 mM sucrose) and permeabilization (3% Triton X-100).
Thereafter, mitochondria were stained with Mitotracker Red CMXRos
(Molecular Probes; 200 nM). The ﬂuorescent images were then ob-
served and analyzed using an Olympus FluoView multi-laser confocal
microscope. For transmission electron microscopy, cells were ﬁxed
(2.5% glutaraldehyde in PBS (pH 7.4) for 1 h at 4 °C) and post-ﬁxed
(1% osmium tetroxide) before embedding in Epon. TEM was
performed with a Philips CM10 instrument at 80 kV using ultra-thin
sections (100 nm on 200 mesh grids) stained with uranyl acetate
and counterstained with lead citrate [39].
2.10. Statistical analysis
The results were expressed as mean±SE and statistical differ-
ences were evaluated by one-way or two-way ANOVA followed by
Tukey's or Bonferroni's post hoc test, using Graph Pad Prism 5.0.
Pb0.05 was considered signiﬁcant. For all experiments data was col-
lected in triplicate from at least three cell lines unless otherwise
indicated.
3. Results
3.1. Trans fats (vaccenic and elaidic acids) induce intrinsic apoptosis and
cell death in primary rat cardiac myoﬁbroblasts
We used a broad range of physiologically relevant concentrations of
vaccenic acid (VA) and elaidic acid (EA) (0, 200 and 400 μM) and treated
primary rat cardiac myoﬁbroblasts cells for up to 72 h to identify theirTime hrs 0 36 48 72 36
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Fig. 2. Both vaccenic and elaidic acids induce rat ventricular myoﬁbroblast apoptosis via act
caspase-3 in total cell lysates of primary cultured rat ventricular myoﬁbroblast. Cells were tr
used as protein loading control. The blots shown are typical of three experiments completed
elaidic acid (200 μM) treatment (up to 72 h) on caspase-8, caspase-9, and caspase-3/-7 e
normalized to that measured for solvent-only treated cultures is represented on the Y-axis
ventricular cell lines (statistical signiﬁcance is indicated by ***Pb0.001 vs untreated controimpact of cell viability and death. The MTT assay indicated that both VA
and EA induce signiﬁcant cell death in a concentration-related manner
at 24 and 72 h (Fig. 1A and B) (Pb0.001). In separate experiments
using FACs assessment of sub-Go nuclear population abundance, we con-
ﬁrmed that loss of viability was associated with signiﬁcant apoptotic cell
death in primary rat cardiac myoﬁbroblasts (Pb0.001 at 72 h) (Fig. 1C
and D). To further discriminate whether apoptosis was linked to intrinsic
or extrinsic effector pathways, we next assessed caspase cleavage and
activation. Both VA and EA activated caspase-3, conﬁrming induction
of apoptosis, and this was associatedwith activation of caspase-9 (intrin-
sic pathway marker) [24,44,45] but not extrinsic pathway markers
[24,46,47], caspase-8 (Fig. 2A–D) or Bid cleavage (data not shown).
We conclude that vaccenic acid and elaidic acid both selectively
induce caspase-dependent intrinsic apoptosis in primary rat cardiac
myoﬁbroblasts.3.2. Trans fats induce autophagy in primary rat cardiac myoﬁbroblasts
LC3 (microtubule-associated protein light chain 3), the mammali-
an equivalent of yeast Atg8, exists in two forms: cytosol-localized
LC3-I, and its lipidated proteolytic derivative LC3-II (18 and 16 kDa,
respectively), which localizes to autophagosomal membranes, and
thus represents a sensitive marker for autophagosome formation
[38,48,49]. In the current study we showed that both VA and EA
(200 μM, 0–72 h) induce LC3β lipidation and LC3β II formation, and
Atg5–12 formation (Fig. 3A) in primary rat cardiac myoﬁbroblasts.
Autophagic ﬂux was conﬁrmed using an inhibitor of lysosome–
autophagosome fusion, Baﬁlomycin A1 (Baf-A1 at 10 nM). Treatment
with Baf-A1 increased LC3β II formation in the presence of either
VA or EA (Fig. 3B), conﬁrming TFA treatment indices de novo
autophagosome formation and subsequent turnover in the absence
of Baf-A1. Transmission electron microscopy further conﬁrmed
autophagosome formation in both VA- and EA-treated cells (Fig. 3C
and D). Finally, another feature of autophagy, lysosomal activation,
indicated by increased in lysotracker red staining, was also induced
by both VA and EA (200 μM, 72 h) (Fig. 3E).Cleaved-Caspase-9 37 kD
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primary rat cardiac myoﬁbroblasts
In healthy cell stasis Bcl2 is localized in the mitochondrial mem-
brane, being tightly associated with Bax (a proapoptotic protein),
and preventing release of apoptogenic factors from the mitochondrial
intermembrane space to the cytoplasm [50–53]. During apoptosis the
balance of pro- and anti-apoptotic proteins shifts, leading to mito-
chondrial damage, decrease in mitochondrial membrane potential,
and release of apoptogenic factors. Both VA and EA affect relative
Bcl2 and Bax abundance in primary rat cardiac myoﬁbroblasts, to
favor apoptosis (Fig. 4A and B). In another study we used BAX knock
out (BAX KO) mouse embryonic ﬁbroblasts (MEFs) and assessed the
effect of VA and EA, compared to wild type MEFs, and showed that
BAX KO MEFs exhibit a signiﬁcantly decreased cytotoxic response to
VA and EA (Fig. 4C, Pb0.001). Subcellular localization of Bax to mito-
chondria is required to promote apoptotic cell death, thus we used a
GFP-Bax over-expressed MEF cell line and assessed the impact ofVA EA 
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Fig. 3. Both vaccenic and elaidic acids induce autophagy in primary rat ventricular my
myoﬁbroblast cells. Cells were treated with 200 μM vaccenic or elaidic acid for the indicate
vaccenic and elaidic acids induce LC3β lipidation and Atg5–12 conjugation. Equal loading
from primary rat ventricular myoﬁbroblast cells. Cells were pre-treated with Baﬁlomycin A
indicated durations, and then immunoblotted using the LC3β antibody. Baﬁlomycin A in
myoﬁbroblast. Equal loading was conﬁrmed using β-actin. (C, D) Rat ventricular primary
200 μM vaccenic (B) or elaidic acid (C) (top panel right and lower panels) for 72 h. Cells were
identiﬁed as autophagosomes or autophagolysosome are indicated within the dotted margin
bar in the right side panel in the middle row represents 2 μm. The lower row shows
myoﬁbroblasts treated with vaccenic and elaidic acids (200 μM, 72 h) showed increased intreatment with VA and EA; both trans fats induced Bax translocation
to mitochondria after 48 h (Fig. 4D). In additional experiments using
rat cardiac myoﬁbroblasts we also observed that VA and EA signiﬁ-
cantly decreased mitochondrial membrane potential (Δψ) after 48 h
(Pb0.001) (Fig. 4E), a time line that correlated with changes in Bax/
Bcl2 expression (Fig. 4A and B) and Bax translocation to mitochondria
(Fig. 4D).
Trans fat exposure has been associated with generation of cyto-
toxic reactive oxygen species (ROS) [54], thus we next determined
whether ROS played a role in EA and VA-induced cell death of rat
cardiac myoﬁbroblasts. We used vitamin C (5 mM) as a ROS scaven-
ger [55,56], and found that it signiﬁcantly inhibited VA and
EA-induced loss of rat cardiac myoﬁbroblast viability (Fig. 4F and
G) (Pb0.05). We also conﬁrmed the involvement of Bcl2 family pro-
teins in VA and EA-induced cell death using BAX/BAK KO MEFs. Of
note MEFs lacking pro-apoptotic Bcl2 proteins (BAX/BAK KO MEFs)
were refractory to the cytotoxic effects exerted by VA and EA
(Fig. 4H–J).LC3  I 
LC3  II 
-actin 
VA
-3
6 
hr
s 
EA
-3
6 
hr
s 
EA
-B
af
-A
1 
36
 h
rs
 
VA
-7
2 
hr
s 
EA
-7
2 
hr
s 
VA
-B
af
-A
1 
36
 h
rs
 
VA
-B
af
-A
1 
72
 h
rs
 
EA
-B
af
-A
1 
72
 h
rs
 
B
af
A1
-3
6 
hr
s 
B
af
A1
-7
2 
hr
s 
A
ut
op
ha
go
so
m
e 
Vaccenic Acid 
oﬁbroblasts. (A) Western blot analysis of cell lysates from primary rat ventricular
d time periods, and then immunoblotted using the indicated speciﬁc antibodies. Both
among lanes was conﬁrmed using β-actin. (B) Western blot analysis of cell lysates
1 (10 nM, 4 h) and then co-treated with 200 μM of either vaccenic or elaidic acid for
duced lapidated LC3β in both vaccenic and elaidic acid treatment in rat ventricular
myoﬁbroblasts were either left untreated (top panel left) or they were treated with
then imaged by transmission electron microscopy. Magniﬁcation: 4.6×103. Structures
. The scale bar represents 2 μm in all the top row and left panel in the middle. The scale
enlarged images of autophagosome and autophagolysosomes. (D) Rat ventricular
Lysotracker Red staining, a marker of lysosomal activation.
Elaidic Acid Control 
La
te
au
to
ph
ag
ol
ys
os
om
e 
A
ut
op
hg
os
om
e 
D 
E 
Fig. 3 (continued).
2279S. Ghavami et al. / Biochimica et Biophysica Acta 1823 (2012) 2274–2286
2280 S. Ghavami et al. / Biochimica et Biophysica Acta 1823 (2012) 2274–22863.4. Autophagy is necessary for VA and EA induced cell death and apopto-
sis induction
Data from several studies indicate that apoptotic and autophagic
cellular processing may be interdependent in some settings but can
be simultaneously regulated and initiated by a common trigger in
other cases, thus resulting in different cellular outcomes [39,57,58].A
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4. Discussion
Our experiments show that trans fats (VA and EA) induce an
intrinsic apoptotic pathway in cardiac myoﬁbroblasts. VA and
EA-induced apoptosis is regulated by Bcl2 family proteins and weH
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vaccenic and elaidic acid treatment (200 μM, 48 h) on mitochondrial trans-membrane poten
were loaded with JC-1 dye and the potential-dependent accumulation in the mitochondria
(spectroﬂuorometry). Data represent the average values from duplicates of three independ
(F and G) Histogram showing effects of Vitamin C on vaccenic and elaidic acid (200 μM, 48
concentration of Vitamin C for 4 h and then co-treated with vaccenic and elaidic acids with
independent experiments. *Pb0.05 compared to time-matched vehicle-or Vitamin C only con
vaccenic (H) and elaidic (I) acids for 36 and 72 h and then photographed under phase contr
BAX/BAK−/− showed no changes in morphology after treatment with vaccenic and elaidic aci
shows the effects of vaccenic and elaidic acids (200 μM, 72 h) on MEF BAX/BAK+/+ and M
vaccenic- and elaidic acid-induced cell death. Data represent the average values from d
***Pb0.001 vs time-matched controls).found that autophagy is required for VA and EA-dependent apoptosis
activation in myoﬁbroblasts.
Dietary TFA is composed of varying amounts of elaidic acid (EA)
and vaccenic acid (VA) isomers. VA is derived from milk, yoghurt,
cheese, butter and from meats of ruminants [59,60]. Several studies
have identiﬁed a link between the ingestion of TFAs and coronary
heart disease [61–64]. TFAs are relatively rare in nature, derived
solely from the diet, and are in abundance in processed foodsG
a altering the balance between Bcl2 pro- and anti-apoptotic proteins. (A) Immunoblot
lasts. Cells were treated with vaccenic and elaidic acids (200 μM) for up to 48 h. Both
oblasts. For all lanes β-actin was used as protein loading control. Blots are typical of
Densitometry analysis showed a signiﬁcant decrease in the ratio of Bcl2/Bax (statistical
yo myoﬁbroblasts (MEF) were treated with either vaccenic or elaidic acid (200 μM for
ch time point were treated with the solvent control (ethanol). Results are expressed as
dent experiments (***, Pb0.001). (D) MEF GFP-Bax expressing cells were treated with
er 48 h of treatment. Both acids induce Bax translocation to mitochondria. (E) Effects of
tial (ΔΨm). After vaccenic and elaidic acid treatment rat ventricular myoﬁbroblast cells
(reduced ΔΨm indicated by a decrease in Red:Green ﬂuorescence) measured directly
ent experiments. ***Pb0.001 compared to time-matched solvent-only treated controls.
h) induced cell death in rat ventricular myoﬁbroblast. Cells pre-treated with indicated
indicated concentration and time point. Data represent the average values from three
trols. (H and I) MEF BAX/BAK +/+ and MEF BAX/BAK−/− cells were treated with 200 μM
ast microscopy settings. Magniﬁed area highlights the effects of acids on the cells. MEF
ds compared to correspondence control. (J) MTT assay is provided in a histogramwhich
EF BAX/BAK−/− cells. BAX/BAK ablation was associated with a signiﬁcant decrease in
uplicates of three independent experiments (statistical signiﬁcance is indicated by
IJ
Fig. 4 (continued).
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source of TFA, Health Canada has issued publicwarnings advising against
the ingestion of TFA [66]. This notwithstanding, the data linking elevated
TFAs to heart disease are indirect—and thus their role in the pathogenesis
of heart disease remains in the focus of intense research. The hypothesis
that reduction of all TFA intake reduces heart disease requires rigorous
scientiﬁc testing [67]. Whether the large number of variables in the epi-
demiological evidence is the source of confusion or as TFA effects may be
masked or exacerbated by other risk factors is a confounding factor, the
need for studies to address the speciﬁc effects of TFAs directly has be-
come a pressing topic for research.
The current study provides evidence that both VA and EA can induce
cell death in rat ventricularmyoﬁbroblasts. VA and EA-induced cell deathincludes both apoptosis and autophagy mechanisms. Apoptosis is a
signiﬁcant factor for normal development of the organisms and formain-
tenance of their homeostasis [68]. Apoptosis is a well-characterized
programmed cell-death pathway that is highly conserved during evolu-
tion, and requires specialized machinery that involves proteases known
as caspases [69]. Furthermore, the Bcl2 protein family, including the
anti-apoptotic members, Bcl2 and Bcl-xL and also the pro-apoptotic
members Bax and Bad, are central regulators of apoptosis by connecting
signals of survival and cell death that are generated within or outside
the cell [70,71]. The imbalance between pro- and anti-apoptotic Bcl2 pro-
teins as well as their localization are the essential apoptosis initiators and
regulators [72,73]. On the other hand it has been shown that a decrease in
mitochondrial membrane potential [74,75] and an increase in cellular
Fig. 5. Inhibition of autophagy decreases vaccenic and elaidic acid induce cell death in rat ventricular myoﬁbroblast. (A and B) MEF ATG5+/+, MEF ATG5−/−, MEF ATG3+/+, and MEF
ATG3−/− cells were treated with 200 μMvaccenic and elaidic acids for 48 h and cell viability wasmeasured usingMTT assay. ATG5 (A) and ATG3 (B) KOwas associated with a signiﬁcant de-
crease in vaccenic and elaidic acid-induced cell death. Data represent the average values fromduplicates of three independent experiments (statistical signiﬁcance is indicated by ***Pb0.001 vs
time-matched controls). (C andD) Immunoblot detection of cleaved caspase-7 and cleaved caspase-3 in total cell lysates derived fromMEF ATG5+/+ (C),MEF ATG5−/− (C),MEF ATG3+/+ (D),
andMEFATG3−/− (D). Cellswere treatedwith vaccenic and elaidic acids (200 μM) for up to 84 h.ATG5 andATG3KDdecrease caspase-7 and caspase-3 cleavages. For all lanesβ-actinwas used
as protein loading control. Blots are typical of three experiments completed using different cultures of different MEF cell lines.
2283S. Ghavami et al. / Biochimica et Biophysica Acta 1823 (2012) 2274–2286
2284 S. Ghavami et al. / Biochimica et Biophysica Acta 1823 (2012) 2274–2286reactive oxygen species (ROS) [76,77] can trigger apoptotic cell death in
different models.
Reactive oxygen species production may trigger and accompany
the activation of the mitochondrial apoptotic pathway [33,41].
The Bcl2 family serves as a checkpoint upstream of mitochondrial
dysfunction [38]. Bcl2 may prevent reactive oxygen species genera-
tion and control the mitochondrial permeability by opposing the ef-
fect of Bax, thereby blocking cytochrome c release [41]. Under
normal conditions, Bax exists as a soluble monomer in cytosol. How-
ever, upon stimulation, Bax translocates to mitochondria and the
level of mitochondrial Bcl2 decreases [78]. Our study shows that
both VA and EA induce mitochondrial caspase-dependent apoptosis
in rVF. VA and EA cause an imbalance between Bax and Bcl2 and
also drive Bax mitochondrial translocation. On the other hand vitamin
C (a general reactive oxygen species scavenger) protects rVF treated
with VA and EA and conﬁrmed a leading role of ROS in TFA-induced
cell death. MEF BAX and BAX/BAK double knock out shows signiﬁcant
resistance toward TFA-induced cell death, which substantiates the es-
sential role of Bcl2 pro-apoptotic protein in TFA-induced cell death.
These data highlight that TFA induces classical, intrinsic pathway mi-
tochondrial apoptotic cell death in rVF.
Evidence obtained from various models supports the idea that both
apoptosis and autophagy can be involved in speciﬁc cell death mecha-
nisms depending on the circumstances [33,38,39,79,80]. Under stress
or cellular damage including starvation, oxidative stress, nutrient depri-
vation and the withdrawal of growth factors, autophagy is induced to
provide the energy necessary to support changes in metabolism or to
aid in the removal of damaged organelles to ensure the survival of the
cell. However, under some conditions, including severe mitochondrial
damage or endoplasmic reticular stress, autophagy can also lead to ap-
optosis and/or alternative pathways of cell death [38,81,82]. Treatment
of rVF with TFA resulted in LC3 lipidation, Atg5–Atg12 conjugation,
and autophagosome formation, conﬁrming a role for autophagy in
TFA-induced cell death in this system. Recently, interest in the mecha-
nistic relationship between apoptosis and autophagy in cell death has
increased [83]. For certain types of apoptotic stimulation, induction of
autophagy is essential for apoptosis to occur [84]. Under these condi-
tions, inhibition of autophagymay delay or even inhibit subsequent ap-
optosis [84,85]. Conversely, autophagy can also act as a protective
mechanism against apoptotic cell death, in which case, blocking
autophagy can enhance apoptosis [33,86]. Using MEF ATG3 and ATG5
KO cells a signiﬁcant decrease in TFA-induced cell death and apoptosis
(caspase-3, and -7 cleavages) in rVF was observed. This would support
an essential function for TFA-induced autophagy in TFA-provoked apo-
ptosis and cell death.
Elucidation of the molecular mechanism(s) of interplay between
autophagy and apoptosis upon TFA-treatment exceeds the objectives
of the current paper. However we hypothesize that VA and EA may
initially affect mitochondrial metabolism, which in turn may lead to
lowered energy production. This then could serve as a powerful trig-
ger for the induction autophagy. Increased mitochondrial metabolism
that ensues may lead to the hyperproduction of reactive oxygen spe-
cies that cause damage in mitochondria and other organelles [87,88].
A hypothetical sequence of events is supported by acquired experi-
mental data in this project e.g., the protective effect of vitamin C (an
antioxidant) and overall slowed kinetics of VA- and EA-induced cell
death.
In conclusion, we observed that moderate concentrations of vaccenic
and elaidic trans fatty acids led to marked apoptotic death of primary rat
cardiac myoﬁbroblasts, and that apoptosis by this stimulus is dependent
upon activation of autophagy.
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